These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23632888)

  • 21. Granulocyte-macrophage colony-stimulating factor receptors alter their binding characteristics during myeloid maturation through up-regulation of the affinity converting beta subunit (KH97).
    Budel LM; Hoogerbrugge H; Pouwels K; van Buitenen C; Delwel R; Löwenberg B; Touw IP
    J Biol Chem; 1993 May; 268(14):10154-9. PubMed ID: 8486685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells.
    Tanimoto A; Murata Y; Wang KY; Tsutsui M; Kohno K; Sasaguri Y
    J Biol Chem; 2008 Feb; 283(8):4643-51. PubMed ID: 18089573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
    Yoshimi A; Balasis ME; Vedder A; Feldman K; Ma Y; Zhang H; Lee SC; Letson C; Niyongere S; Lu SX; Ball M; Taylor J; Zhang Q; Zhao Y; Youssef S; Chung YR; Zhang XJ; Durham BH; Yang W; List AF; Loh ML; Klimek V; Berger MF; Stieglitz E; Padron E; Abdel-Wahab O
    Blood; 2017 Jul; 130(4):397-407. PubMed ID: 28576879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of granulocyte-macrophage colony-stimulating factor gene expression by a tumor necrosis factor specific ribozyme in juvenile myelomonocytic leukemic cells.
    Iversen PO; Sioud M
    Blood; 1998 Dec; 92(11):4263-8. PubMed ID: 9834232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells.
    Chan CH; Blazar BR; Eide CR; Kreitman RJ; Vallera DA
    Blood; 1995 Oct; 86(7):2732-40. PubMed ID: 7670112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion.
    Iwasaki-Arai J; Iwasaki H; Miyamoto T; Watanabe S; Akashi K
    J Exp Med; 2003 May; 197(10):1311-22. PubMed ID: 12756267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure.
    Dirksen U; Hattenhorst U; Schneider P; Schroten H; Göbel U; Böcking A; Müller KM; Murray R; Burdach S
    Blood; 1998 Aug; 92(4):1097-103. PubMed ID: 9694696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping of human granulocyte-macrophage-colony-stimulating-factor domains interacting with the human granulocyte-macrophage-colony-stimulating-factor-receptor alpha-subunit.
    Brown CB; Pihl CE; Kaushansky K
    Eur J Biochem; 1994 Nov; 225(3):873-80. PubMed ID: 7957224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and function of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit.
    Jubinsky PT; Laurie AS; Nathan DG; Yetz-Aldepe J; Sieff CA
    Blood; 1994 Dec; 84(12):4174-85. PubMed ID: 7994031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement.
    Gaipa G; Bugarin C; Longoni D; Cesana S; Molteni C; Faini A; Timeus F; Zecca M; Biondi A
    Leukemia; 2009 Apr; 23(4):791-3. PubMed ID: 18830265
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML).
    Padron E; Dezern A; Andrade-Campos M; Vaddi K; Scherle P; Zhang Q; Ma Y; Balasis ME; Tinsley S; Ramadan H; Zimmerman C; Steensma DP; Roboz GJ; Lancet JE; List AF; Sekeres MA; Komrokji RS;
    Clin Cancer Res; 2016 Aug; 22(15):3746-54. PubMed ID: 26858309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells.
    Everson MP; Brown CB; Lilly MB
    Blood; 1989 Oct; 74(5):1472-6. PubMed ID: 2676012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia.
    Nakazawa Y; Matsuda K; Kurata T; Sueki A; Tanaka M; Sakashita K; Imai C; Wilson MH; Koike K
    J Hematol Oncol; 2016 Mar; 9():27. PubMed ID: 26983639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation.
    Matsuguchi T; Zhao Y; Lilly MB; Kraft AS
    J Biol Chem; 1997 Jul; 272(28):17450-9. PubMed ID: 9211889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations.
    Metzner A; Horstmann MA; Fehse B; Ortmeyer G; Niemeyer CM; Stocking C; Mayr GW; Jücker M
    Gene Ther; 2007 Apr; 14(8):699-703. PubMed ID: 17268534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.
    Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA
    Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoplasmic domains of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor beta chain (hbetac) responsible for human GM-CSF-induced myeloid cell differentiation.
    Matsuguchi T; Lilly MB; Kraft AS
    J Biol Chem; 1998 Jul; 273(31):19411-8. PubMed ID: 9677359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice.
    Iversen PO; Lewis ID; Turczynowicz S; Hasle H; Niemeyer C; Schmiegelow K; Bastiras S; Biondi A; Hughes TP; Lopez AF
    Blood; 1997 Dec; 90(12):4910-7. PubMed ID: 9389708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.